|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities (amortized cost of $26,265,637 and $25,170,368; allowance for expected credit losses of $440 and $74 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Investment funds | ||||||||||||||||||||
| Real estate | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Arbitrage trading account | ||||||||||||||||||||
| Loans receivable (net of allowance for expected credit losses of $0 and $161 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Premiums and fees receivable (net of allowance for expected credit losses of $41,421 and $42,006 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Due from reinsurers (net of allowance for expected credit losses of $6,808 and $6,378 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Trading account receivables from brokers and clearing organizations | ||||||||||||||||||||
| Property, furniture and equipment | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Current federal and foreign income taxes | ||||||||||||||||||||
| Deferred federal and foreign income taxes | ||||||||||||||||||||
| Current and deferred federal and foreign income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Reserves for losses and loss expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Due to reinsurers | ||||||||||||||||||||
| Trading account securities sold but not yet purchased | ||||||||||||||||||||
| Current federal and foreign income taxes | ||||||||||||||||||||
| Current and deferred federal and foreign income taxes | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Senior notes and other debt | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Perferred stock, par value $.10 per share: Authorized 5,000,000 shares; issued and outstanding - none | ||||||||||||||||||||
| Common stock, par value $.20 per share: Authorized 500,000,000 shares, issued and outstanding, net of treasury shares, 177,930,502 and 183,411,907 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost, 422,464,027 and 416,366,010 shares, respectively | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common stock, authorized (in shares) | ||||||||||||||||||||
| Liability recognized for best estimate net of reinsurance, reported losses | ||||||||||||||||||||
Loading...
